FH
Fairmount Healthcare Fund II L.P.
DELAYED 1 MONTH
Director; Director, 10% Owner
CRESCENT BIOPHARMA, INC.
Jade Biosciences, Inc.
Oruka Therapeutics, Inc.
Spyre Therapeutics, Inc.
Viridian Therapeutics, Inc.\DE
Filings
5
Companies
5
Latest
Jun 9, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
66
VRDN+30% IN
Viridian Therapeutics, Inc.\DE
Fairmount Healthcare Fund II L.P.
Director, 10% Owner
Purchase
$20.0M
1,176,470 sh
May 13 8:31 PM
May 11, 2026